Description: In an interview with Bloomberg Editor-in-Chief John Micklethwait, one of the people most responsible for helping to vaccinate the world against Covid-19 discusses how his company is navigating the pandemic.
Date: Jan 28, 2021
Questions for discussion:
- From a financial point of view, does this report suggest Pfizer will have long term benefits from its investments in vaccines?
- Should investors consider vaccines an important part of Pfizer’s portfolio?
- What does the report suggest about the management of the firm?